Personalized starting age of gastric cancer screening based on individuals' risk profiles: a population-based, prospective study

被引:1
|
作者
He, Siyi [1 ]
Zhang, Zhiyi [2 ]
Song, Guohui [3 ]
Wang, Zhenhai [4 ]
Li, He [5 ]
Cao, Maomao [1 ]
Yang, Fan [1 ]
Sun, Dianqin [1 ,6 ]
Yan, Xinxin [1 ]
Zhang, Shaoli [1 ]
Teng, Yi [1 ]
Li, Qianru [1 ]
Xia, Changfa [1 ]
Chen, Wanqing [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Off Canc Screening, Natl Clin Res Ctr Canc,Natl Canc Ctr, 17 Pan jia yuan South Lane, Chaoyang 100021, Peoples R China
[2] Gansu Wuwei Tumor Hosp, Dept Gastroenterol, Wuwei, Peoples R China
[3] Hosp Ci Cty, Dept Epidemiol, Canc Inst, Handan, Peoples R China
[4] Linzhou Canc Hosp, Dept Gen Surg, Linzhou, Peoples R China
[5] China Med Univ, Affiliated Hosp 1, Off Natl Canc Reg Med Ctr Liaoning Prov, Shenyang, Peoples R China
[6] Univ Med Ctr, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands
来源
基金
中国国家自然科学基金;
关键词
CHINA; ESOPHAGUS; DYSPLASIA; MORTALITY; LINXIAN; TRENDS;
D O I
10.1093/jnci/djae162
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The current recommended starting age for gastric cancer screening lacks unified guideline and individualized criteria. We aimed to determine the risk-stratified starting age for gastric cancer screening in China based on individuals' risk profiles and to develop an online calculator for clinical application.Methods In this multicenter, population-based, prospective study, we allocated participants enrolled between 2015 and 2017 (N = 59 771, aged 40-69 years) to screened and unscreened groups and observed them for primary endpoints: gastric cancer occurrence as well as all-cause and gastric cancer-specific death. Median follow-up was 6.07 years. To determine the reference starting age, the effectiveness of gastric cancer screening was assessed by age group after propensity score matching. Further, we categorized the calculated individual risk scores (using well-established risk factors) by quantile. Subsequently, we used age-specific, 10-year cumulative risk curves to estimate the risk-stratified starting age-that is, when the individual's risk level matches the reference starting age risk threshold.Results During follow-up, 475 gastric cancer case patients, 182 gastric cancer-related deaths, and 1860 all-cause deaths occurred. All-cause and gastric cancer-specific mortality decreased among screened individuals 45 years of age and older and 50 to 59 years of age, respectively. Thus, the average population (referent) starting age was set as 50 years. The 10-year cumulative risk of gastric cancer in the average population aged 50 years was 1.147%. We stratified the starting age using 8 risk factors and categorized participants as low-risk, medium-risk, and high-risk individuals whose risk-stratified starting age was 58, 50, and 46 years, respectively.Conclusion Although high-risk individuals warrant starting gastric cancer screening 3 to 5 years earlier than for the average population (aged 50 years), low-risk individuals can tolerate delayed screening. Our online, personalized starting age calculator will help with risk-adapted gastric cancer screening (https://web.consultech.com.cn/gastric/#/).
引用
收藏
页码:1775 / 1783
页数:9
相关论文
共 50 条
  • [31] Factors associated with participation in colorectal cancer screening: A population-based study of 7200 individuals
    Huang, Junjie
    Choi, Peter
    Pang, Tiffany W. Y.
    Chen, Xiao
    Wang, Jingxuan
    Ding, Hanyue
    Jin, Yinzi
    Zheng, Zhi-Jie
    Wong, Martin C. S.
    EUROPEAN JOURNAL OF CANCER CARE, 2021, 30 (02)
  • [32] Risk stratification among individuals attending population-based sigmoidoscopy screening
    Hol, L.
    van Leerdam, M. E.
    van Ballegooijen, M.
    Kuipers, E. J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (07) : A74 - A75
  • [33] PERFORMANCE OF A POPULATION-BASED SCREENING PROGRAM TARGETED AT HIGH RISK INDIVIDUALS
    Wong, Martin C.
    Ching, Jessica Y.
    Lam, Thomas Y.
    Kyaw, Moe H.
    Lo, Angeline
    Luk, Arthur K. C.
    Ng, Simpson K. C.
    Wu, Justin C.
    Chan, Francis K.
    Sung, Joseph J.
    GASTROENTEROLOGY, 2018, 154 (06) : S575 - S575
  • [34] Diabetes and risk of subsequent gastric cancer: a population-based cohort study in Taiwan
    Yu-Lung Chen
    Kao-Chi Cheng
    Shih-Wei Lai
    I-Ju Tsai
    Che-Chen Lin
    Fung-Chang Sung
    Cheng-Chieh Lin
    Pei-Chun Chen
    Gastric Cancer, 2013, 16 : 389 - 396
  • [35] Proton pump inhibitors and risk of gastric cancer: A population-based cohort study
    Abrahami, Devin
    McDonald, Emily G.
    Schnitzer, Mireille
    Barkun, Alan
    Suissa, Samy
    Azoulay, Laurent
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 13 - 14
  • [36] Diabetes and risk of subsequent gastric cancer: a population-based cohort study in Taiwan
    Chen, Yu-Lung
    Cheng, Kao-Chi
    Lai, Shih-Wei
    Tsai, I-Ju
    Lin, Che-Chen
    Sung, Fung-Chang
    Lin, Cheng-Chieh
    Chen, Pei-Chun
    GASTRIC CANCER, 2013, 16 (03) : 389 - 396
  • [37] Proton pump inhibitors and risk of gastric cancer: population-based cohort study
    Abrahami, Devin
    McDonald, Emily Gibson
    Schnitzer, Mireille E.
    Barkun, Alan N.
    Suissa, Samy
    Azoulay, Laurent
    GUT, 2022, 71 (01) : 16 - 24
  • [38] Proton pump inhibitors and risk of gastric cancer: a population-based cohort study
    Poulsen, A. H.
    Christensen, S.
    McLaughlin, J. K.
    Thomsen, R. W.
    Sorensen, H. T.
    Olsen, J. H.
    Friis, S.
    BRITISH JOURNAL OF CANCER, 2009, 100 (09) : 1503 - 1507
  • [39] Aspirin and risk for gastric cancer: a population-based case–control study in Sweden
    K Akre
    A M Ekström
    L B Signorello
    L-E Hansson
    O Nyrén
    British Journal of Cancer, 2001, 84 : 965 - 968
  • [40] Autoimmune conditions and gastric cancer risk in a population-based study in the United Kingdom
    Murphy, John D.
    Gadalla, Shahinaz M.
    Anderson, Lesley A.
    Rabkin, Charles S.
    Cardwell, Chris R.
    Song, Minkyo
    Camargo, M. Constanza
    BRITISH JOURNAL OF CANCER, 2024, 131 (01) : 138 - 148